Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03655626 · ClinicalTrials.gov registry record · NA
Implementation and Evaluations of Sepsis Watch
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 32,003
- Enrollment target
NCT03655626: Completed NA study, sponsored by Duke University.
NCT03655626 is a NA study that has completed, run by Duke University. The registered enrollment target is 32,003 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2181% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03655626, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 32,003 participants
- Enrollment target
Study Summary
The purpose of this study is to study the implementation and impact of an early warning system to detect and treat sepsis in the emergency room. We are observing the implementation of a Sepsis Machine Learning Model on all Adult patients. All data (observations field notes, interview recording \& transcripts, and survey responses) will be stored on HIPAA-compliant Duke servers behind the Duke firewall, and requiring password-protected user authentication to access. The risk to patients is minimal. The two risks to interviewed clinical staff we have identified involve loss of work time and anonymity.
Primary Outcome
Proportion of patients with sepsis that complete Center for Medicare and Medicaid Services treatment bundle
Interventions
- OTHER Sepsis Watch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32,003 participants |
| Start Date | 2018-11-05 |
| Est. Completion | 2019-07-05 |
| Phase | NA |
What the finished NCT03655626 record still lists
NCT03655626 is an interventional study that assigns participants to a tested intervention. Its 32,003 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2181% higher).
The record links to 0 conditions, and to 1 intervention - of which Sepsis Watch is the first listed.
NCT03655626 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03655626 about?
NCT03655626 is a clinical study titled "Implementation and Evaluations of Sepsis Watch". The purpose of this study is to study the implementation and impact of an early warning system to detect and treat sepsis in the emergency room. We are observing the implementation of a Sepsis Machine Learning Model on all Adult patients. All data (observations field notes, interview recording \& tr...
What is the current status of trial NCT03655626?
This trial is currently completed. It is a NA study. The enrollment target is 32,003 participants. The study started on 2018-11-05. Estimated completion is 2019-07-05.
What interventions are being tested in trial NCT03655626?
The interventions under investigation include: Sepsis Watch (OTHER).
Who is sponsoring clinical trial NCT03655626?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03655626's enrollment target sits among peer trials
32,003 8th of 2000 higher than 1,993 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07282665 · 32,000 participants · Phase 3
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
- NCT04477928 · 33,000 participants
General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
- NCT06145724 · 33,183 participants · NA
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)
- NCT00684580 · 30,000 participants
Protocol For Collecting Data On Patients With Childhood Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI